Efficacy of Individualized Homoeopathic medicines or Bowel nosodes compared to placebo in irritable bowel syndrome: A three-armed, randomized, parallel group, placebo-controlled, double-blind, interventional trial. - NI

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•i)Patients fulfilling the Rome IV criteria.
•ii)Adults both male and female aged 18 to 60 years.
•iii)The willingness to document bowel symptoms and medication use regularly and to complete the assessments.

•i)Pregnant or breast feeding female.
•ii)Patient who had prior abdominal surgery which may cause bowel symptoms similar to IBS.
•iii)Those who had other gastro-intestinal diseases including Colitis, Crohn’s disease, Coeliac disease and Chronic pancreatitis.
•iv)Those who were currently participating in another trial or had been in a trial within the previous three months.
•v)Patient with any uncontrolled co-morbidities (Hypertension, Diabetes Mellitus, Liver disease, kidney disease, heart disease, hypo or hyperthyroidism etc.)
•vi)Patients who are alcoholics.
•vii)Patient taken antispasmodics, opiates/anti-diarrhoeal drugs, NSAIDs, long-term antibiotics, other anti- inflammatory drugs in the last 15 days.
•viii)Poor treatment compliance (e.g. unstable working and living situation, difficult follow-up).

发起方

Central Council for Research in Homoeopathy